Conv. Plasma
Nigella Sativa

All ivermectin studies
Meta analysis
study COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle

Lifschitz et al., Veterinary Parasitology, doi:10.1016/s0304-4017(99)00175-2
Feb 2000  
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
*, now known with p < 0.00000000001 from 100 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments.
Pharmacokinetic analysis of ivermectin in cattle, showing that tissue concentration can be several times higher than plasma concentration.
Lifschitz et al., 29 Feb 2000, peer-reviewed, 7 authors. Contact:
This PaperIvermectinAll
Comparative distribution of ivermectin and doramectin to parasite location tissues in cattle
A Lifschitz, G Virkel, J Sallovitz, J F Sutra, P Galtier, M Alvinerie, C Lanusse
Pharmacokinetic studies have been used traditionally to characterize drug concentration profiles achieved in the bloodstream. However, endectocide molecules exert their persistent and broad spectrum activity against parasites localized in many different tissues. The aim of this study was to compare the distribution of ivermectin (IVM) and doramectin (DRM) to different tissues in which parasites are found following subcutaneous administration to calves. Holstein calves weighing 120-140 kg were injected in the shoulder area with commercially available formulations of IVM (Ivomec 1% MSD AGVET, NJ, USA) (Group A) or DRM (Dectomax 1%, Pfizer, NY, USA) (Group B). Two treated calves were sacrificed at 1, 4, 8, 18, 28, 38, 48 or 58 days post-treatment. Plasma, abomasal and small intestinal fluids and mucosal tissues, bile, faeces, lung and skin samples were collected, extracted, derivatized and analyzed by high performance liquid chromatography (HPLC) with fluorescence detection to determine IVM and DRM concentrations. IVM and DRM were distributed to all the tissues and fluids analyzed. Concentrations >0.1 ng/ml (ng/g) were detected between 1 and 48 days post-treatment in all the tissues and fluids investigated. At 58 days post-treatment, IVM and DRM were detected only in bile and faeces, where large concentrations were excreted. Delayed T max values for DRM (4 days post-administration) compared to those for IVM (1 day) were observed in the different tissues and fluids. High IVM and DRM concentrations were measured in the most important target tissues, including skin. The highest IVM and DRM concentrations were measured in abomasal mucosa and lung tissue. Enhanced availabilities of both IVM (between 45 and 244%) and DRM (20-147%) were obtained in tissues compared to plasma. There was good correlation between concentration profiles of both compounds in plasma and target
Alvinerie, Sutra, Galtier, Ivermectin in goat milk after subcutaneous injection, Vet. Res
Alvinerie, Sutra, Galtier, Lifschitz, Virkel et al., Persistence of ivermectin in plasma and faeces following administration of a sustained-release bolus to cattle, Res. Vet. Sci
Armour, Bairden, Batty, Davison, Ross, Persistent anthelmintic activity of ivermectin in cattle, Vet. Rec
Baggot, Principles of Drug Disposition: The Basis of Veterinary Clinical Pharmacology
Benz, Roncalli, Gross, Use of ivermectin in cattle, sheep, goats and swine
Bogan, Mckellar, The pharmacodynamics of ivermectin in sheep and cattle, J. Vet. Pharmacol. Ther
Chiu, Green, Baylis, Eline, Rosegay et al., Absorption, tissue distribution, and excretion of tritium-labelled ivermectin in cattle, sheep, and rat, J. Agric. Food Chem
Eichler, Müller, Drug distribution. The forgotten relative in clinical pharmacokinetics, Clin. Pharmacokinet
Fisher, Mrozik, Chemistry
Geary, Klein, Vanover, Bowman, Thompson, The nervous systems of helminths as targets for drugs, J. Parasitol
Geary, Sims, Thomas, Vanover, Davis et al., Haemonchus contortus: ivermectin-induced paralysis of the pharynx, Exp. Parasitol
Gibaldi, Perrier, Pharmacokinetics, 2nd ed (revised and expanded)
Gill, Lacey, Avermectin/milbemycin resistance in trichostrongyloid nematodes, Int. J. Parasitol
Gill, Redwin, Van Wyk, Lacey, Detection of resistance to ivermectin in Haemonchus contortus, Int. J. Parasitol
Gonzalez, Muniz, Farias, Goncalves, Rew, Therapeutic and persistent efficacy of doramectin against Boophilus microplus in cattle, Vet. Parasitol
Goudie, Evans, Gration, Bishop, Gibson et al., None, Vet. Parasitol
Jackson, Ivermectin as a systemic insecticide, Parasitol. Today
Jones, Logan, Weatherley, Little, Smothers, Activity of doramectin against nematode endoparasites of cattle, Vet. Parasitol
Lanusse, Lifschitz, Virkel, Alvarez, Sanchez et al., Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle, J. Vet. Pharmacol. Ther
Lifschitz, Virkel, Imperiale, Sutra, Galtier et al., Moxidectin in cattle: Correlation between plasma and target tissues disposition, J. Vet. Pharmacol. Ther
Logan, Weatherley, Phillips, Wilkins, Shanks, Spectrum of activity of doramectin against cattle mites and lice, Vet. Parasitol
Mckellar, Benchaoui, Avermectins and milbemycins, J. Vet. Pharmacol. Ther
Ranjan, Trudeau, Prichard, Daigneault, Rew, Nematode reinfection following treatment of cattle with doramectin and ivermectin, Vet. Parasitol
Toutain, Upson, Terhune, Mckenzie, Comparative pharmacokinetics of doramectin and ivermectin in cattle, Vet. Parasitol
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop